Venture Valuation conducts an independent valuation of Genedata, a Swiss start-up company in order to help Novartis Venture Fund analyze and structure the next financing round. Venture Valuation, under a tight investment timeframe, has to customize the evaluation process, using both quantitative and qualitative data, to meet the customers needs. The case outlines Genedata’s background, its product portfolio, competitive positioning, and issues that it will need to deal with in the near future. Learning Objective: This case is part of a three case series intended to draw the audience into the issues surrounding the valuation of a startup biotechnology company, one of the most speculative and volatile marketplace.
2000-2005
Cranfield University
Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]
Harvard Business School Publishing
60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]
NUCB Business School
1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]
IMD retains all proprietary interests in its case studies and notes. Without prior written permission, IMD cases and notes may not be reproduced, used, translated, included in books or other publications, distributed in any form or by any means, stored in a database or in other retrieval systems. For additional copyright information related to case studies, please contact Case Services.
Research Information & Knowledge Hub for additional information on IMD publications
- Genedata
- Novartis Venture Fund: Valuation dilemmas
- Venture Valuation AG: The genedata assignment
- Genedata
- Novartis Venture Fund: Valuation dilemmas
- Venture Valuation AG: The genedata assignment
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-1-0242 ©2005
Research Information & Knowledge Hub for additional information on IMD publications
Case reference: IMD-1-0241 ©2005
Research Information & Knowledge Hub for additional information on IMD publications
AI is revolutionizing finance, boosting productivity and insights, but CFOs must invest in infrastructure, navigate regulations, and upskill teams for a successful future.
Brookfield’s Catalytic Transition Fund is a case study in how the financial industry can spearhead sustainable development. Brookfield Asset Management announced an initial closing of $2.4 billion for the Catalytic Transition Fund, marking a signi...
Explore top books, websites, and podcasts recommended by IMD expert Jim Pulcrano for anyone venturing into or exploring venture capital, from entrepreneurs to investors.
LPX AG, founded in 2004 by Michel Degosciu and Robin Jakob, is a leader in listed alternatives, focusing on listed private equity (LPE) and listed infrastructure. With its pioneering LPX Listed Private Equity Index series and NMX Infrastructure In...
As CIO at VenCap, David Clark leads the Investment Team, developing the firms’ investment strategy, fund identification, selection and monitoring. Founded in 1987, Vencap is one of the longest-established investment management and advisory firms a...
Anne has recently been named the CFO of a large multinational manufacturing group. It is a big change of direction: before this, she worked as a senior consultant with a top consultancy. Her appointment stems from a long and successful relationshi...
Green and sustainability-linked bonds offer companies new funding to reach urgent sustainability goals. Salvatore Cantale and Barry Gavin explain how to make the most of a booming market.
Bold and unproven ideas may struggle to attract early investment, but that doesn't mean they are doomed to fail.
In this episode of Capital Conversations, Sia Houchangnia presents a specific approach to providing effective advice and support to founders.
SEPTEMBER 2023, SÃO PAULO (BRAZIL). Gustavo Buffara was painstakingly putting the finishing touches on the IG4 Private Equity Fund III presentation. Co-founded by Gustavo in 2016, IG4 Capital had grown to become a leading force in private equity i...
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD 18 December 2024
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
in I by IMD 14 December 2024
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications
Research Information & Knowledge Hub for additional information on IMD publications